Quantitative positron emission tomography imaging to measure tumor response to therapy: What is the best method?

Molecular Imaging and Biology

Volumn 5, Issue 5, 2003, Pages 281-285

  Mankoff, David A ^a   Muzi, Mark ^a   Krohn, Kenneth A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' FLUOROTHYMIDINE; ACETIC ACID; CARBON 11; CHOLINE; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GLUCOSE; RADIOPHARMACEUTICAL AGENT; THYMIDINE DERIVATIVE;

ACCURACY; CANCER CHEMOTHERAPY; CANCER THERAPY; CLINICAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG TRANSPORT; DRUG UPTAKE; EDITORIAL; ESOPHAGUS CANCER; GLUCOSE METABOLISM; HUMAN; IMAGE ANALYSIS; MEASUREMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION RESPONSE; RADIOISOTOPE DISTRIBUTION; TISSUE DISTRIBUTION; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME;

EID: 0345874559     PISSN: 15361632     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mibio.2003.09.002     Document Type: Article

References (22)

1. Hoffman E. van der Stee M. Ricci A. Phelps M. Prospects for both precision and accuracy in positron emission tomography Ann. Neurol. 15 1984 S25-S34
2. Huang S.-C. Anatomy of SUV Nucl. Med. Biol. 27 2000 643-646
3. 18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods Eur. J. Nucl. Med. 27 2000 731-743
4. Graham M.M. Peterson L.M. Hayward R.M. Comparison of simplified quantitative analyses of FDG uptake Nucl. Med. Biol. 27 2000 647-655
5. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat J. Neurochem. 28 1977 897-916
6. 11C]deoxyglucose J. Cereb. Blood Flow Metab. 5 1985 179-192
7. Phelps M.E. Huang S.C. Hoffman E.J. Selin C. Sokoloff L. Kuhl D.E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method Ann. Neurol. 6 1979 371-388
8. Spence A. Muzi M. Graham M. et al. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant J. Nucl. Med. 39 1998 440-448
9. Gjedde A. Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination Brain Res. Rev. 4 1982 237-274
10. Patlak C.S. Blasberg R.G. Fenstermacher J.D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data J. Cereb. Blood Flow Metab. 3 1983 1-7
11. Eary J.F. Mankoff D.A. Determination of tumor metabolic rates in sarcoma using FDG PET: practical approaches J. Nucl. Med. 39 1998 250-254
12. Woodward H.Q. Bigler R.E. Freed B. Russ G. Expression of tissue isotope distribution J. Nucl. Med. 16 1975 958-959
13. Keyes J.W.J. SUV: standard uptake or silly useless value? J. Nucl. Med. 36 1995 1836-1839
14. Kim C.K. Gupta N. Chandramouli B. Alavi A. Stardized uptake values of FDG: body surface area correction is preferable to body weight correction J. Nucl. Med. 35 1994 164-167
15. Zasadny K.R. Wahl R.L. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction Radiology 189 1993 847-850
16. Hunter G. Hamberg L. Alpert N. Choi N. Fischman A. Simplified measurement of deoxyglucose utilization rate J. Nucl. Med. 37 1996 950-955
17. Kroep J.R. Van Groeningen C.J. Cuesta M.A. et al. Positron emission tomography using 2-deoxy-2-[F-18]-fuoro-D-glucose for response monitoring in locally advanced gastroesophogeal cancer; a comparison of different analytic methods Mol. Imag. Biol. 5 2003 337-346
18. Young H. Baum R. Cremerius U. et al. Measurement of clinical and subclinical tumour response using [F-18]-fluorodoxyglucose and positron emission tomography: review and 1999 EORTC recommendations Eur. J. Cancer 35 1999 1773-1782
19. Krohn K.A. Mankoff D.A. Eary J.F. Imaging cellular proliferation as a measure of response to therapy J. Clin. Pharmacol. 41 2001 96S-103S
20. Shields A.F. Mankoff D.A. Link J.M. et al. Carbon-11-thymidine and FDG to measure therapy response J. Nucl. Med. 39 1998 1757-1762
21. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse J. Nucl. Med. 44 2003 549-555
22. 99mTc-annexin V J. Nucl. Med. 40 1999 184-191